title: No evidence for evolution of protease inhibitor resistance from standard genotyping, after three years of treatment with darunavir/ritonavir, with or without nucleoside analogues.
authors.forename: Federico
authors.initials: F
authors.lastname: Pulido
authors.forename: Jose
authors.initials: J
authors.lastname: Arribas
authors.forename: Andrew
authors.initials: A
authors.lastname: Hill
authors.forename: Christiane
authors.initials: C
authors.lastname: Moecklinghoff
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000494:pharmacology*; D000069454:Darunavir; D024882:Drug Resistance, Viral; D005838:Genotype; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006801:Humans; D009705:Nucleosides / Q000494:pharmacology; D012367:RNA, Viral / Q000187:drug effects*; D019438:Ritonavir / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology*; D013997:Time Factors; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D009705:Nucleosides; D012367:RNA, Viral; D013449:Sulfonamides; D019438:Ritonavir; D000069454:Darunavir